Table 5.
Adjusted PR (95% CI)a
|
||
---|---|---|
Covariate | Multiple tablet users | Single tablet users |
Specific drug typeb | ||
None | 1 | 1 |
Marijuana use only | 1.02 (0.91–1.14) | 1.48 (1.11–1.97) |
Other | 1.40 (1.23–1.60) | 1.87 (1.29–2.70) |
Race/Ethnicity | ||
Black, non-Hispanic | 1 | 1 |
White, non-Hispanic/Other | 0.80 (0.68–0.94) | 0.49 (0.27–0.89) |
Hispanic | 0.73 (0.64–0.83) | 0.55 (0.37–0.83) |
Depressive symptoms | 1.08 (1.00–1.17) | 1.52 (1.22–1.89) |
Currently employed | – | 0.97 (0.74–1.27) |
Annual income > $12,000 | 0.99 (0.92–1.08) | – |
Alcohol use (drinks/week)b | ||
Abstainer (0) | 1 | – |
Moderate (1–7) | 1.17 (1.09–1.27) | |
Heavy (>7) | 1.26 (1.11–1.42) | |
Current smoking | 1.22 (1.11–1.33) | – |
CD4+ cell count | ||
<350 | 1 | 1 |
350–499 | 0.87 (0.80–0.95) | 0.74 (0.55–0.98) |
≥500 | 0.79 (0.72–0.87) | 0.76 (0.57–1.02) |
Detectable HIV viral load | 1.28 (1.19–1.37) | 1.22 (0.98–1.53) |
PR, prevalence ratio; CI, confidence interval
Estimates were adjusted for age at baseline visit, calendar year, and enrollment cohort.
In the 6 months prior to the study visit